Search papers, labs, and topics across Lattice.
The paper introduces a novel framework for optimizing deep generative models for molecular design by integrating a D-Wave quantum annealing computer. A Neural Hash Function (NHF) is used for regularization and binarization, facilitating the interaction between classical and quantum neural networks in the objective function. The quantum-annealing generative models produced compounds with improved validity and drug-likeness compared to classical models, even surpassing the drug-likeness of compounds in the training data.
Quantum annealing can push generative AI models for molecular design beyond the limitations of their training data, achieving higher drug-likeness without explicit constraints.
Deep generative modeling to stochastically design small molecules is an emerging technology for accelerating drug discovery and development. However, one major issue in molecular generative models is their lower frequency of drug-like compounds. To resolve this problem, we developed a novel framework for optimization of deep generative models integrated with a D-Wave quantum annealing computer, where our Neural Hash Function (NHF) presented herein is used both as the regularization and binarization schemes simultaneously, of which the latter is for transformation between continuous and discrete signals of the classical and quantum neural networks, respectively, in the error evaluation (i.e., objective) function. The compounds generated via the quantum-annealing generative models exhibited higher quality in both validity and drug-likeness than those generated via the fully-classical models, and was further indicated to exceed even the training data in terms of drug-likeness features, without any restraints and conditions to deliberately induce such an optimization. These results indicated an advantage of quantum annealing to aim at a stochastic generator integrated with our novel neural network architectures, for the extended performance of feature space sampling and extraction of characteristic features in drug design.
